BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34635181)

  • 1. Deciphering genes associated with diffuse large B-cell lymphoma with lymphomatous effusions: A mutational accumulation scoring approach.
    Abdollahi S; Dehghanian SZ; Hung LY; Yang SJ; Chen DP; Medeiros LJ; Chiang JH; Chang KC
    Biomark Res; 2021 Oct; 9(1):74. PubMed ID: 34635181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant effusions correlate with poorer prognosis in patients with diffuse large B-cell lymphoma.
    Chen YP; Huang HY; Lin KP; Medeiros LJ; Chen TY; Chang KC
    Am J Clin Pathol; 2015 May; 143(5):707-15. PubMed ID: 25873505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusions.
    Carbone A; Cilia AM; Gloghini A; Canzonieri V; Pastore C; Todesco M; Cozzi M; Perin T; Volpe R; Pinto A; Gaidano G
    Int J Cancer; 1997 Nov; 73(4):562-9. PubMed ID: 9389573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.
    Nador RG; Cesarman E; Chadburn A; Dawson DB; Ansari MQ; Sald J; Knowles DM
    Blood; 1996 Jul; 88(2):645-56. PubMed ID: 8695812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleural Effusions in Diffuse Large B-Cell Lymphoma: Clinical and Prognostic Significance.
    Porcel JM; Cuadrat I; García-Cerecedo T; Pardina M; Bielsa S
    Lung; 2019 Feb; 197(1):47-51. PubMed ID: 30506166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined cytomorphologic and immunophenotypic analysis in the diagnostic workup of lymphomatous effusions.
    Bangerter M; Hildebrand A; Griesshammer M
    Acta Cytol; 2001; 45(3):307-12. PubMed ID: 11393059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma.
    You H; Xu-Monette ZY; Wei L; Nunns H; Nagy ML; Bhagat G; Fang X; Zhu F; Visco C; Tzankov A; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; Hagemeister FB; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; Van Krieken JH; Piris MA; Winter JN; Li Y; Au Q; Xu B; Albitar M; Young KH
    Oncoimmunology; 2021; 10(1):1928365. PubMed ID: 34350060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of USP25 promotes progression of human diffuse large B-cell lymphoma through blocking the ubiquitinated degradation of MDM2.
    Yang H; Liu Y; Yang J; Zhang Q; Wang H; Chen Y; Zhou K
    Biochem Biophys Res Commun; 2023 Oct; 676():21-29. PubMed ID: 37480689
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Dobashi A; Togashi Y; Tanaka N; Yokoyama M; Tsuyama N; Baba S; Mori S; Hatake K; Yamaguchi T; Noda T; Takeuchi K
    Oncotarget; 2018 Apr; 9(28):19555-19568. PubMed ID: 29731965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory characteristics of lymphoid neoplasms in serous effusions: a single centre experience in China.
    Gong X; Shao S; Jin L; Fu Y; Wang L; Xiao X; Yang L; Zhao X
    Diagn Cytopathol; 2020 Dec; 48(12):1173-1180. PubMed ID: 32757383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
    Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
    Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
    Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a five-gene signature associated with stromal infiltration for diffuse large B-cell lymphoma.
    Nan YY; Zhang WJ; Huang DH; Li QY; Shi Y; Yang T; Liang XP; Xiao CY; Guo BL; Xiang Y
    World J Clin Cases; 2021 Jun; 9(18):4585-4598. PubMed ID: 34222425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS).
    Carreras J; Kikuti YY; Beà S; Miyaoka M; Hiraiwa S; Ikoma H; Nagao R; Tomita S; Martin-Garcia D; Salaverria I; Sato A; Ichiki A; Roncador G; Garcia JF; Ando K; Campo E; Nakamura N
    Histopathology; 2017 Mar; 70(4):595-621. PubMed ID: 27775850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma.
    Singh RR; Kunkalla K; Qu C; Schlette E; Neelapu SS; Samaniego F; Vega F
    Oncogene; 2011 Dec; 30(49):4874-86. PubMed ID: 21625222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.
    Lohr JG; Stojanov P; Lawrence MS; Auclair D; Chapuy B; Sougnez C; Cruz-Gordillo P; Knoechel B; Asmann YW; Slager SL; Novak AJ; Dogan A; Ansell SM; Link BK; Zou L; Gould J; Saksena G; Stransky N; Rangel-Escareño C; Fernandez-Lopez JC; Hidalgo-Miranda A; Melendez-Zajgla J; Hernández-Lemus E; Schwarz-Cruz y Celis A; Imaz-Rosshandler I; Ojesina AI; Jung J; Pedamallu CS; Lander ES; Habermann TM; Cerhan JR; Shipp MA; Getz G; Golub TR
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3879-84. PubMed ID: 22343534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma.
    Li P; Chai J; Chen Z; Liu Y; Wei J; Liu Y; Zhao D; Ma J; Wang K; Li X; Shao Y; Gong L; Zhang W; Guo S; Yan Q; Li M; Fan L; Wang Z
    Front Oncol; 2021; 11():622648. PubMed ID: 33747936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma.
    Mareschal S; Dubois S; Viailly PJ; Bertrand P; Bohers E; Maingonnat C; Jaïs JP; Tesson B; Ruminy P; Peyrouze P; Copie-Bergman C; Fest T; Jo Molina T; Haioun C; Salles G; Tilly H; Lecroq T; Leroy K; Jardin F
    Genes Chromosomes Cancer; 2016 Mar; 55(3):251-67. PubMed ID: 26608593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.
    Juskevicius D; Jucker D; Klingbiel D; Mamot C; Dirnhofer S; Tzankov A
    J Hematol Oncol; 2017 Mar; 10(1):70. PubMed ID: 28302137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.